Reltech Biomedical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
- Paid Up Capital ₹ 0.51 M
- Company Age 37 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
About Reltech Biomedical Systems
Reltech Biomedical Systems Ltd (RBSL) is a Public Limited Indian Non-Government Company incorporated in India on 19 October 1987 and has a history of 37 years and three months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.51 M, as per Ministry of Corporate Affairs (MCA) records.
Birupaksha Sarkar, Narayani Sarkar, and Vinay Kapadia serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239WB1987PLC043177
-
Company No.
043177
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Oct 1987
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Reltech Biomedical Systems?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Birupaksha Sarkar
|
Managing Director | 01-Oct-1990 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Narayani Sarkar
|
Director | 10-Apr-1995 | Current |
|
Vinay Kapadia
|
Director | 19-Oct-1987 | Current |
Financial Performance of Reltech Biomedical Systems.
Reltech Biomedical Systems Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reltech Biomedical Systems?
In 2017, Reltech Biomedical Systems had a promoter holding of 99.70% and a public holding of 0.30%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
_LTD.webp)
B A & Brothers (Eastern) Private LtdVinay Kapadia is a mutual person
-
Bio Speciality Assay Lab Private LimitedBirupaksha Sarkar, Narayani Sarkar and 1 more are mutual person
-
Kapadia Trading Private Limited
Vinay Kapadia is a mutual person
-
S C B Consultants Pvt Ltd
Vinay Kapadia is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reltech Biomedical Systems?
Unlock and access historical data on people associated with Reltech Biomedical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reltech Biomedical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reltech Biomedical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.